SCHEMBL5013115

SCHEMBL5013115

CC(C)CCCOC(=O)/C=C/c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.61
LMNA P02545 3/20 0.60
TDP1 Q9NUW8 1/20 0.60
AKR1B10 O60218 6/20 0.60
AKR1B1 P15121 6/20 0.60
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAOB P27338 1/20 0.51
APP P05067 1/20 0.51
ESR1 P03372 1/20 0.51
ALOX5 P09917 1/20 0.49
CA12 O43570 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA5A P35218 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
NFKB1 P19838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16616720 0.96 ALDH1A1 (0.60) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL6567707 0.94 ALDH1A1 (0.59) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL81835 0.91 LMNA (0.72) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL81836 0.91 LMNA (0.72) ALDH1A1LMNATDP1AKR1B10AKR1B1
Methyl Alcohol SCHEMBL21995794 0.90 LMNA (0.70) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL24691968 0.89 LMNA (0.59) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL24691226 0.89 LMNA (0.59) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL29817892 0.88 ESR1 (0.49) ALDH1A1LMNATDP1AKR1B10AKR1B1
SCHEMBL15347088 0.86 AKR1B10 (0.73) ALDH1A1LMNAAKR1B10AKR1B1MEN1
SCHEMBL12083424 0.86 AKR1B10 (0.73) ALDH1A1LMNAAKR1B10AKR1B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025133665-A1 OIL-IN-WATER EMULSION L V M H RECHERCHE (FR) 2025-06-26 WO disclosed
EP-4452208-A1 AQUEOUS EMULSION L V M H RECHERCHE (FR) 2024-10-30 EP disclosed
WO-2023118912-A1 AQUEOUS EMULSION L V M H RECHERCHE (FR) 2023-06-29 WO disclosed
US-20230040911-A1 Oil-In-Water-Type Emulsion Cosmetic L V M H RECHERCHE (FR) 2023-02-09 US disclosed
EP-4076348-A1 OIL-IN-WATER-TYPE EMULSION COSMETIC L V M H RECHERCHE (FR) 2022-10-26 EP disclosed
WO-2021151452-A1 OIL-IN-WATER-TYPE EMULSION COSMETIC L V M H RECHERCHE (FR) 2021-08-05 WO disclosed
EP-3197563-B1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC UV-SCREENING AGENT AND A FILLER OREAL (FR) 2019-10-30 EP disclosed
EP-3546025-A2 USE OF OLEOGELS IN UV ABSORBER COMPOSITIONS BASF SE (DE) 2019-10-02 EP disclosed
US-20190117783-A1 COMPOSITIONS HOSLER, JAMES P. 2019-04-25 US disclosed
EP-2773201-B1 IMPROVED COMPOSITIONS COMPRISING POVIDONE-IODINE COMPLEX MICRODERMIS CORP (US) 2017-12-06 EP disclosed
WO-2016030193-A1 COMPOSITION BASED ON A LIPOPHILIC ORGANIC SCREENING AGENT AND A FILLER L'OREAL (FR) 2016-03-03 WO disclosed
EP-2773201-A1 IMPROVED COMPOSITIONS Microdermis Corporation (US) 2014-09-10 EP disclosed
US-20130121953-A1 COMPOSITIONS MICRODERMIS CORPORATION (US) 2013-05-16 US disclosed
WO-2013066909-A1 IMPROVED COMPOSITIONS MICRODERMIS CORPORATION (US) 2013-05-10 WO disclosed
EP-1465587-B1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2012-08-01 EP disclosed
US-20080131381-A1 METHODS FOR PHOTOSTABILIZING INGREDIENTS WITHIN COSMETICS, PERSONAL CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS OBTAINED THEREFROM MERCK PATENT GESELLSCHAFT (DE) 2008-06-05 US disclosed
EP-1465587-A1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2004-10-13 EP disclosed
US-6652843-B2 Containing fiber forming nonpolymeric structurant such as n-acyl aminoacid amide and/or cyclodipeptide UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. 2003-11-25 US disclosed
US-20030180240-A1 Clear solid suspension; molding material UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-09-25 US disclosed
WO-2003059308-A1 ANTIPERSPIRANT COMPOSITIONS UNILEVER PLC (GB) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040911-A1 Oil-In-Water-Type Emulsion Cosmetic CUTA, PHOSPHO1, LIPE ALDH1A1 4132/4885LMNA 874/4885TDP1 1496/4885
US-20190117783-A1 COMPOSITIONS POLE3, POLR1C, SSTR3 ALDH1A1 1482/4885LMNA 4634/4885TDP1 643/4885
US-20080131381-A1 METHODS FOR PHOTOSTABILIZING INGREDIENTS WITHIN COSMETICS, PERSONAL CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS OBTAINED THEREFROM TYR, NISCH, PPOX ALDH1A1 742/4885LMNA 1693/4885TDP1 3083/4885
US-20030180240-A1 Clear solid suspension; molding material GRIA1, GLG1, GPR27 ALDH1A1 743/4885LMNA 3636/4885TDP1 923/4885
US-20130121953-A1 COMPOSITIONS POLE3, POLR1C, SSTR3 ALDH1A1 1482/4885LMNA 4634/4885TDP1 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.